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Summary. An important character of the eye is 
transparency, so intraocular neovascularization, which is 
fragile and likely to result in hemorrhage, would cause a 
functional disorder of the eye and contribute to loss of 
vision associated with such diseases as retinopathy of 
prematurity, diabetic retinopathy, retinal vein occlusion, 
and age-related macular degeneration. Recently interest 
in the mechanisms of intraocular neovascularization has 
increased, and the mechanisms have been gradually 
elucidated using several in vitro and in vivo angio- 
genesis models. Blood vessels in the eye are composed 
of, and surrounded by, various types of cells that 
produce multiple factors. Neovascularization is regulated 
by complex interactions among these angiogenic factors, 
angiostatic factors, and adhesion molecules, and some of 
these angiogenesis-related molecules have also been 
suggested as new targets for novel therapeutic agents of 
intraocular neo-vascularization. This review focuses on 
in vivo representative angiogenesis models of the 
corneal pocket model and the model of oxygen-induced 
retinopathy, and discusses the role of some angiogenesis- 
related factors and adhesion molecules in intraocular 
neovascularization. 
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Introduction 
Angiogenesis, the formation of new capillary blood 
vessels, is essential for development, tissue regeneration, 
and remodeling. Angiogenesis also accompanies 
pathological conditions, including tumor growth, 
rheumatoid arthritis, psoriasis, and diabetic retinopathy 
(Folkman, 1995). Intraocular neovascularization is a 
major cause of blindness associated with such diseases 
as retinopathy of prematurity, diabetic retinopathy, 
retinal vein occlusion, and age-related macular 
degeneration (Diabetic Retinopathy Study Research 
Group, 1981; Brown et al., 1987; Prost, 1988; Moss et 
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al., 1994; Thylefors et al., 1995). Retinopathy of 
prematurity occurs in premature neonates. In the 
premature baby the retina remains incompletely 
vascularized at the time of birth. Abnormal new 
proliferating vessels develop at the junction of 
vascularized and avascular retinas. Diabetic retinopathy 
is the most frequent cause of blindness in individuals of 
working age. In patients with diabetes mellitus, retinal 
capillary occlusions develop, creating areas of ischemic 
retina followed by neovascular proliferations from pre- 
existing retinal venules. Occlusion of the central or 
branch retinal vein induces hemorrhage, edema, 
exudates, and nonperfused retina followed by neo- 
vascularization mainly in adulthood. Age-related 
macular degeneration is a major cause of visual loss in 
persons over 65 years old. In age-related macular 
degeneration, neovascularization develops from 
choroidal vasculature, and extends into the subretinal 
space in the macula, the area of retina responsible for 
central vision. The neovascularization associated with 
these disorders commonly involves increased 
permeability of the retinal vasculature resulting in 
transduction of serum components into the retina and 
visual loss from macular edema. In addition, the 
neovascularization itself can lead to visual loss due to 
the fragility of the new vessels resulting in vitreous 
hemorrhage or  due to progressive fibrovascular 
proliferation and contraction that may lead to macular 
traction, traction retinal detachment or rhegmatogenous 
retinal detachment (Patz, 1980; Aiello, 1997). 
Recently the interest in the mechanisms of intra- 
ocular neovascularization has increased. No single 
growth factor acts alone to cause intraocular neo- 
vascularization. Neovascularization is induced by 
complex interactions among multiple angiogenic factors, 
angiostatic factors, and adhesion molecules. In this 
review, we focus on the mechanisms of intraocular 
neovascularization in which a variety of factors interact. 
In vivo angiogenesis model 
To understand the precise mechanisms of intraocular 
neovascularization developing in vivo and in vitro 
angiogenesis model systems is important, and so  far 
several angiogenesis model systems have been 
developed. Among them, the corneal pocket model and 







